Literature DB >> 1425123

Islet amyloid: an enigma of type 2 diabetes.

A Clark1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425123     DOI: 10.1002/dmr.5610080204

Source DB:  PubMed          Journal:  Diabetes Metab Rev        ISSN: 0742-4221


× No keyword cloud information.
  5 in total

1.  Heterogeneity in distribution of amyloid-positive islets in type-2 diabetic patients.

Authors:  Cecilia M Borromeo; Xavier Pottier; Peter A In't Veld; Miriam A Pipeleers-Marichal; Leonard Kaufman; Daniel G Pipeleers; Christiaan F Van Schravendijk
Journal:  Virchows Arch       Date:  2005-01-27       Impact factor: 4.064

Review 2.  Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy.

Authors:  C Oosterwijk; J W Höppener; K L van Hulst; C J Lips
Journal:  Int J Pancreatol       Date:  1995-08

3.  Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia.

Authors:  J W Höppener; J S Verbeek; E J de Koning; C Oosterwijk; K L van Hulst; H J Visser-Vernooy; F M Hofhuis; S van Gaalen; M J Berends; W H Hackeng
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

4.  Amyloid formation in response to beta cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide.

Authors:  G Westermark; M B Arora; N Fox; R Carroll; S J Chan; P Westermark; D F Steiner
Journal:  Mol Med       Date:  1995-07       Impact factor: 6.354

5.  Rapid deposition of amyloid in human islets transplanted into nude mice.

Authors:  P Westermark; D L Eizirik; D G Pipeleers; C Hellerström; A Andersson
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.